跳至主要内容
临床试验/NCT05974228
NCT05974228尚未招募不适用

Bioglass Wound Dressing in Treatment of Chronic Wound in Different Stage:a Randomized Controlled Trial

Peking University Third Hospital0 个研究点目标入组 80 人开始时间: 2023年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
主要终点
2-week reduction rate of wound area

研究概览

简要总结

The goal of this randomized control trial is to test the efficacy and safety of a bioglass wound dressing in patients with chronic wound in different stages. The main question it aims to answer are:

  • Whether the bioglass wound dressing have better efficacy and safety than blank control in treatment of chronic wound in necrosis stable stage?
  • Whether the bioglass wound dressing have better efficacy and safety than blank control in treatment of chronic wound in granulation growth stage? Participants will be assigned with a 1:1 ratio into intervention group and control group.

Participants of intervention group will receive bioglass wound dressing in addition with clinical optimal treatment plan. Participants of control group will only receive clinical optimal treatment plan.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patient is aged 18-80 years old;
  • Ulcerative wounds;
  • In the stage of stable necrosis or granulation growth;
  • Voluntarily participate in this study and sign an informed consent form

排除标准

  • Severe diseases such as acute myocardial infarction, heart failure, hepatitis, shock, and respiratory failure have not been corrected yet;
  • Uncontrolled blood glucose, Glucose test#Fasting blood sugar>15mmol/L, Glycated hemoglobin>12%;
  • There is active bleeding inside the wound, and routine basic treatment plans cannot be implemented;
  • Serum albumin < 20 g/L; Hemoglobin<60 g/L; Platelets<50 × 10^9/L;
  • Spreading infection status, currently or about to be treated with antibiotics;
  • Patients with advanced malignant tumors;
  • Active period of autoimmune diseases;
  • Previous allergies to bioactive glass ointment dressings (self originating);
  • The patient is unable to cooperate or has mental disorders;
  • According to the judgment of the researcher, the subject has a clear reason that cannot be removed and affects wound healing, which is not suitable for this study or cannot comply with the requirements of this study.

结局指标

主要结局

2-week reduction rate of wound area

时间窗: 2-week

次要结局

  • 2-week wound healing rate(2-week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Long Zhang

Professor

Peking University Third Hospital

相似试验